Sysmex (OTCMKTS:SSMXY) Shares Gap Down – Time to Sell?

Shares of Sysmex Corporation ADR (OTCMKTS:SSMXY) gapped down before the market opened on Monday. The stock had previously closed at $11.77, but opened at $11.15. Sysmex shares last traded at $11.15, with a volume of 62,316 shares traded.

Analysts Set New Price Targets

Separately, Zacks Research upgraded shares of Sysmex from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 18th. One analyst has rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold”.

Sysmex Price Performance

The firm has a market capitalization of $7.50 billion, a PE ratio of 28.36 and a beta of 1.18. The company has a fifty day moving average price of $11.70 and a two-hundred day moving average price of $9.89. The company has a current ratio of 3.40, a quick ratio of 2.53 and a debt-to-equity ratio of 0.23.

Sysmex (OTCMKTS:SSMXY) last announced its earnings results on Friday, August 7th. The company reported $0.09 EPS for the quarter, beating analysts’ consensus estimates of $0.07 by $0.02. The business had revenue of $825.85 million for the quarter, compared to analysts’ expectations of $741.67 million. Sysmex had a net margin of 7.62% and a return on equity of 8.01%. Sysmex has set its FY 2026 guidance at 0.382-0.382 EPS. Sell-side analysts forecast that Sysmex Corporation ADR will post 0.41 earnings per share for the current year.

Sysmex Company Profile

Sysmex Corporation is a Japan-based healthcare technology company that develops, manufactures and distributes in vitro diagnostic products and laboratory solutions. The company is best known for its automated hematology analyzers, which are used to examine blood cells, along with related reagents, software and support services.

Its product portfolio also includes systems for hemostasis, urinalysis, clinical chemistry and immunochemistry, as well as laboratory automation and information-management solutions.